Ray Dalio's ALKS Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 344,452 shares of Alkermes plc (ALKS) worth $9.64 M, representing 0.04% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ALKS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 344,452 shares. Largest reduction occurred in Q1 2024, reducing 33,584 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Alkermes plc (ALKS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alkermes plc (ALKS) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +344,452 | New Buy | 344,452 | $27.98 |
| Q2 2024 | -7,400 | Sold Out | 0 | $0.00 |
| Q1 2024 | -33,584 | Reduce 81.94% | 7,400 | $27.07 |
| Q4 2023 | +8,083 | Add 24.57% | 40,984 | $27.74 |
| Q3 2023 | -1,367 | Reduce 3.99% | 32,901 | $28.01 |
| Q2 2023 | -223 | Reduce 0.65% | 34,268 | $31.30 |
| Q1 2023 | -6,046 | Reduce 14.91% | 34,491 | $28.19 |
| Q4 2022 | +12,311 | Add 43.62% | 40,537 | $26.13 |
| Q3 2022 | -1,427 | Reduce 4.81% | 28,226 | $22.32 |
| Q2 2022 | +2,041 | Add 7.39% | 29,653 | $29.78 |
| Q1 2022 | +8,280 | Add 42.83% | 27,612 | $26.29 |
| Q4 2021 | +2,449 | Add 14.51% | 19,332 | $23.28 |
| Q3 2021 | +589 | Add 3.61% | 16,883 | $30.86 |
| Q2 2021 | +16,294 | New Buy | 16,294 | $24.55 |
Ray Dalio's Alkermes plc Investment FAQs
Ray Dalio first purchased Alkermes plc (ALKS) in Q2 2021, acquiring 16,294 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Alkermes plc (ALKS) for 14 quarters since Q2 2021.
Ray Dalio's largest addition to Alkermes plc (ALKS) was in Q4 2025, adding 344,452 shares worth $9.64 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 344,452 shares of Alkermes plc (ALKS), valued at approximately $9.64 M.
As of the Q4 2025 filing, Alkermes plc (ALKS) represents approximately 0.04% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Alkermes plc (ALKS) was 344,452 shares, as reported at the end of Q4 2025.